Victory Capital Management Inc. Has $289.55 Million Position in Agilent Technologies, Inc. (NYSE:A)

Victory Capital Management Inc. trimmed its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 6.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,155,325 shares of the medical research company's stock after selling 140,492 shares during the period. Victory Capital Management Inc. owned about 0.75% of Agilent Technologies worth $289,546,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in A. Vestal Point Capital LP acquired a new position in shares of Agilent Technologies during the third quarter worth about $14,848,000. Empowered Funds LLC boosted its position in shares of Agilent Technologies by 29.8% during the third quarter. Empowered Funds LLC now owns 30,978 shares of the medical research company's stock worth $4,592,000 after buying an additional 7,111 shares during the period. S.E.E.D. Planning Group LLC boosted its position in shares of Agilent Technologies by 12.7% during the fourth quarter. S.E.E.D. Planning Group LLC now owns 42,587 shares of the medical research company's stock worth $5,721,000 after buying an additional 4,805 shares during the period. National Pension Service boosted its position in shares of Agilent Technologies by 10.8% during the third quarter. National Pension Service now owns 702,631 shares of the medical research company's stock worth $104,327,000 after buying an additional 68,670 shares during the period. Finally, Miracle Mile Advisors LLC acquired a new position in shares of Agilent Technologies during the fourth quarter worth about $362,000.

Remove Ads

Wall Street Analyst Weigh In

A has been the subject of several recent research reports. Wells Fargo & Company reduced their price objective on Agilent Technologies from $157.00 to $155.00 and set an "overweight" rating for the company in a research report on Monday, December 9th. Sanford C. Bernstein reduced their price objective on Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating for the company in a research report on Tuesday, November 26th. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Robert W. Baird dropped their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating on the stock in a report on Thursday, February 27th. Finally, JPMorgan Chase & Co. dropped their target price on Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating on the stock in a report on Tuesday, November 26th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat.com, Agilent Technologies currently has an average rating of "Moderate Buy" and an average price target of $146.15.

Insider Transactions at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total transaction of $286,650.00. Following the transaction, the chief executive officer now owns 39,652 shares in the company, valued at approximately $5,947,800. This trade represents a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Agilent Technologies Stock Performance

NYSE:A traded up $0.04 on Friday, hitting $126.59. The company's stock had a trading volume of 2,056,080 shares, compared to its average volume of 1,836,046. The company has a current ratio of 2.20, a quick ratio of 1.66 and a debt-to-equity ratio of 0.56. The stock has a fifty day moving average of $139.67 and a two-hundred day moving average of $138.69. The firm has a market capitalization of $36.09 billion, a P/E ratio of 29.10, a price-to-earnings-growth ratio of 3.55 and a beta of 1.11. Agilent Technologies, Inc. has a one year low of $121.45 and a one year high of $155.35.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.27 by $0.04. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. Research analysts predict that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.

Agilent Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be paid a dividend of $0.248 per share. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.78%. Agilent Technologies's dividend payout ratio (DPR) is currently 22.76%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.